Biotheranostics privacy statement

Privacy statement

This privacy statement governs your use of Biotheranostics’s website and all information you provide to Biotheranostics on our website.

Notice of privacy practices

This Notice of privacy practices describes how Biotheranostics may use and disclose individuals’ health information, whether collected on our website or off-line, and is posted in compliance with HIPAA.

Questions

If you have questions about the Biotheranostics privacy statement, please contact us at privacy@biotheranostics.com.

View our Terms and Conditions.



1. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Breast Cancer V.3.2022. © National Comprehensive Cancer Network, Inc. 2022. All rights reserved. Accessed April 27, 2022. To view the most recent and complete version of the guideline, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way 2. Andre F et al. J Clin Oncol. Published online April 19, 2022. DOI: 10.1200/JCO.22.00069

Hologic, Biotheranostics, Breast Cancer Index, CancerTYPE ID and associated logos are trademarks and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries. All other trademarks, registered trademarks and product names are the property of their respective owners.